InceptionR’s Arbutus Biopharma ABUS Stock Holding History

InceptionR’s Portfolio ABUS Stock Details ABUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$147K	Buy	32,580 +4,162	+15%	+$18.2K	0.04%	602
2025 Q4	$137K	Buy	+28,418	New	+$128K	0.04%	570

Other funds holding ABUS

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TSC

Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return

WCM

Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

InceptionR's ABUS Position: Q1 2026 in Review

InceptionR increased its Arbutus Biopharma (ABUS) stake by 15% in Q1 2026, buying an estimated $18.2K and bringing the position to 32,580 shares worth $147K. The position accounts for 0.04% of the portfolio, ranked #602.

InceptionR first reported a position in ABUS in Q4 2025 and has held it in 2 quarters since. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

InceptionR held 32,580 shares of Arbutus Biopharma worth $147K as of Q1 2026.
InceptionR bought 4,162 Arbutus Biopharma shares in Q1 2026, an estimated $18.2K.
Arbutus Biopharma made up 0.04% of InceptionR's portfolio in Q1 2026, its #602 holding.
InceptionR first reported a position in Arbutus Biopharma in Q4 2025 and has held it in 2 quarters since.
167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on InceptionR's 13F filing for Q1 2026, filed 14 May 2026.